MarketPulse

pediatric patients

3 articles
BenzingaBenzinga··Vandana Singh

Novo Nordisk Advances Oral GLP-1 Therapy for Young Diabetics

Novo Nordisk reports positive phase 3a trial results for oral semaglutide in children with type 2 diabetes, planning 2026 regulatory filings for potential first pediatric GLP-1 approval.
NVOregulatory approvalOzempic
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Mesoblast Wins FDA Green Light for Direct Path to DMD Approval Trial

Mesoblast receives IND clearance to proceed directly to registrational trial for Ryoncil in Duchenne muscular dystrophy, potentially accelerating path to market approval.
MESORyoncil®cell therapy
BenzingaBenzinga··Vandana Singh

Novartis Expands Cosentyx Reach Into Pediatric Dermatology With FDA Approval

Novartis wins FDA approval for Cosentyx in pediatric hidradenitis suppurativa patients aged 12+, marking the drug's fourth pediatric indication and expanding its dermatology portfolio.
NVSFDA approvalautoimmune disease